- Home
- AEI vs VANI Comparison
AEI vs VANI Comparison
Compare AEI & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEI | VANI |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4M | 95.8M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AEI | VANI |
|---|---|---|
| Price | $2.29 | $1.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 21.1K | ★ 321.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 93.40 | 14.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,238,200.00 | $4,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.70 | $0.91 |
| 52 Week High | $4.55 | $1.92 |
Technical Indicators
Market Signals| Indicator | AEI | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 37.75 | 43.34 |
| Support Level | $1.13 | $1.17 |
| Resistance Level | $3.61 | $1.24 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 13.64 | 38.89 |
Price Performance
Historical ComparisonAbout AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.